Is Grand Capital Ventures stock a sell signal?
Is Grand Capital Ventures Inc. stock A Buy?
stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.29 and $1.46. A breakdown below any of these levels will issue sell signals. Grand Capital Ventures Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 28, 2021, and so far it has fallen -12.24%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD).
How do I buy Grand Capital Ventures Inc (GRCV) stock?
Grand Capital Ventures Inc. holds several positive signals , but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
What sector and industry does Grand Capital Ventures Inc (GRCV) operate in?
You can purchase shares of Grand Capital Ventures Inc ( OTC: GRCV) through any online brokerage.
Greencity Acquisition Corporation Announces It Has Regained Compliance with Nasdaq Listing Requirements
Grand Capital Ventures Inc is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.
Greencity Acquisition Corporation Announces to Extend Deadline to Consummate Business Combination
Greencity Acquisition Corporation (NASDAQ: GRCY) (the "Company") received a letter on August 6, 2021 from Nasdaq stating, that based on the Company's filing of its Form 10-Q for the quarter ended March 31, 2021 on July 26, 2021, Nasdaq has determined that the Company now complies with the filing criteria established in Nasdaq Listing Rule 5250 (c) (1)..
Greencity Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Greencity Acquisition Corporation (the "Company" or "Greencity") (NASDAQ: GRCY) (the "Company") today announced that the Company's sponsor, Cynthia Management Corporation (the "Sponsor"), has deposited into the Company's trust account (the "Trust Account") an aggregate of $133,334, representing $0.033 per public share of the Company, in order to extend the period of time the Company has to consummate a business combination by one month to August 28, 2021..
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma
Greencity Acquisition Corporation (NASDAQ: GRCY) (the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion.
Gracell Biotechnologies to Participate in Citi 2022 Virtual Immuno-Oncology Summit
Gracell Biotechnologies Inc.
